U-M researchers find adults with cerebral palsy more likely to have chronic conditions

December 01, 2015

ANN ARBOR, Mich. - A new study from the University of Michigan finds adults with cerebral palsy are more likely to have secondary chronic health conditions, such as diabetes and high blood pressure, than adults without cerebral palsy.

The findings raise questions about how to prevent or reduce these conditions among the high-risk population.

Cerebral palsy is a pediatric neurodevelopmental disorder caused by damage to the brain, generally before birth. It results in a wide range of physical and developmental problems such as uncontrollable movements or muscular activity, loss of muscle tone and strength, and weakened reflexes and balance, in addition to a wide-range of medical and cognitive difficulties such as swallowing, seizures, and orthopedic abnormalities.

"As a father of a child with cerebral palsy, I'm dedicated to improving the scientific evidence and clinical care of this growing population," says lead author Mark Peterson, Ph.D., M.S., assistant professor of physical medicine and rehabilitation at the University of Michigan.

"Unfortunately, it's still not fully understood how to best care for individuals with cerebral palsy as they transition into and throughout adulthood. We sought to determine whether adults with cerebral palsy suffer from secondary chronic health conditions more frequently, and how that can affect future medical care for this population," he adds.

The new study, published Dec. 1 in JAMA, measured the prevalence estimates of eight, lifestyle-related chronic health conditions in both adults with cerebral palsy and those without.

The research team used data from the Medical Expenditure Panel Survey, a set of large-scale surveys conducted by the Agency for Healthcare Research and Quality to find and collect data on health care services, usage and costs. The study included 207,615 adults, ages 18 or older, with 1,015 of those having cerebral palsy.

The team determined adults with cerebral palsy were between two and five times more likely to have these chronic health conditions than adults without cerebral palsy. After adjusting for age, numerous sociodemographic factors, body mass index, physical activity, and degree of disability, they still found the prevalence of chronic health conditions significantly greater in adults with cerebral palsy.

Specifically, they found:

They also found age, sex, obesity, degree of physical disability and physical inactivity to be significantly associated with each of the chronic conditions.

Peterson says the results indicate chronic health conditions are much more common in adults with cerebral palsy and should raise questions among fellow health care providers.

"Because cerebral palsy results in accelerated losses of mobility with age, individuals tend to experience more fatigue and have greater muscle and joint pain over time. We found physical inactivity and immobility were strongly associated with these chronic health conditions," Peterson says.

"Therefore, we need to strongly consider how these health complications could further impact this population, and how we can prevent or reduce these conditions among individuals with cerebral palsy through their lifespan."
-end-
Authors: In addition to Peterson, the study's authors include Edward Hurvitz, M.D., chair of the U-M Department of Physical Medicine and Rehabilitation, Elham Mahmoudi, Ph.D., of the U-M Department of Surgery, and Jennifer Ryan, Ph.D., of the Brunel University of London Institute of Environment, Health and Societies.

Funding: Funding for the study came from the National Institutes of Health (grant 1KO1 HD074706).

Disclosures: none.

Reference: JAMA, http://dx.doi.org/10.1001/jama.2015.11025.

University of Michigan Health System

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.